Are some IBD drugs safer for seniors? massive medicare study aims to find out

NCT ID NCT07250815

Not yet recruiting Knowledge-focused Sponsor: Takeda Source: ClinicalTrials.gov ↗

Summary

This study aims to compare the risk of serious infections in older adults (65+) with Ulcerative Colitis or Crohn's Disease when they start different advanced medications. It will look back at the medical records of about 23,900 people on Medicare from 2016 to 2025 to see if one type of drug leads to fewer infections requiring hospitalization than others. The goal is to gather safety information to help doctors and patients make better treatment choices.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.